coronary artery disease

Rationale and design of BERLIN VT study: a multicenter randomised trial comparing preventive versus deferred ablation of ventricular tachycardia
Roland Richard Tilz, Karl-Heinz Kuck, Stephan Kääb, Karl Wegscheider, Annette Thiem, Beate Wenzel, Stephan Willems, Daniel Steven

BMJ Open May 2019, 9 (5) e022910; DOI: 10.1136/bmjopen-2018-022910
Application of speCtraL computed tomogrAphy to impRove specIficity of cardiac compuTed tomographY (CLARITY study): rationale and design
Robbert Willem van Hamersvelt, Ivana Išgum, Pim A de Jong, Maarten Jan Maria Cramer, Geert E H Leenders, Martin J Willemink, Michiel Voskuil, Tim Leiner

BMJ Open Mar 2019, 9 (3) e025793; DOI: 10.1136/bmjopen-2018-025793
Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort
Maria Wanitschek, Michael Edlinger, Jakob Dörler, Hannes F Alber

BMJ Open Jun 2018, 8 (6) e021808; DOI: 10.1136/bmjopen-2018-021808
Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case–control study
Yueyue You, Yan-Hua Wu, Yangyu Zhang, Lili Zhang, Yan Song, Wei Bai, Yuanyuan Li, Yaqin Yu, Changgui Kou

BMJ Open Jun 2018, 8 (6) e020016; DOI: 10.1136/bmjopen-2017-020016
Patient confidence regarding secondary lifestyle modification and knowledge of ‘heart attack’ symptoms following percutaneous revascularisation in Japan: a cross-sectional study
Hiroki Kitakata, Takashi Kohno, Shun Kohsaka, Junko Fujino, Naomi Nakano, Ryoma Fukuoka, Shinsuke Yuasa, Yuichiro Maekawa, Keiichi Fukuda

BMJ Open Mar 2018, 8 (3) e019119; DOI: 10.1136/bmjopen-2017-019119
Is exercise-based cardiac rehabilitation effective? A systematic review and meta-analysis to re-examine the evidence
Richard Powell, Gordon McGregor, Stuart Ennis, Peter K Kimani, Martin Underwood

BMJ Open Mar 2018, 8 (3) e019656; DOI: 10.1136/bmjopen-2017-019656
Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial
Pan-pan Tian, Jun Li, Jian Gao, Ying Li

BMJ Open Feb 2018, 8 (2) e018052; DOI: 10.1136/bmjopen-2017-018052
Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America
Joseph A Ladapo, Adrian Coles, Rowena J Dolor, Daniel B Mark, Lawton Cooper, Kerry L Lee, Jonathan Goldberg, Michael D Shapiro, Udo Hoffmann, Pamela S Douglas

BMJ Open Sep 2017, 7 (9) e016364; DOI: 10.1136/bmjopen-2017-016364
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
Sheng-Hua Yang, Ying Du, Yan Zhang, Xiao-Lin Li, Sha Li, Rui-Xia Xu, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Ping Qing, Ying Gao, Chuan-Jue Cui, Qian Dong, Jing Sun, Jian-Jun Li

BMJ Open Jun 2017, 7 (6) e015041; DOI: 10.1136/bmjopen-2016-015041
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome—a prospective multicentre biomarker study conducted in the Netherlands
Rohit M Oemrawsingh, K Martijn Akkerhuis, Victor A Umans, Bas Kietselaer, Carl Schotborgh, Eelko Ronner, Timo Lenderink, Anho Liem, David Haitsma, Pim van der Harst, Folkert W Asselbergs, Arthur Maas, Anton J Oude Ophuis, Ben Ilmer, Rene Dijkgraaf, Robbert-Jan de Winter, S Hong Kie The, Alexander J Wardeh, Walter Hermans, Etienne Cramer, Ron H van Schaik, Imo E Hoefer, Pieter A Doevendans, Maarten L Simoons, Eric Boersma

BMJ Open Dec 2016, 6 (12) e012929; DOI: 10.1136/bmjopen-2016-012929

Main menu

coronary artery disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

coronary artery disease

Pages